0001558370-24-004668.txt : 20240515 0001558370-24-004668.hdr.sgml : 20240515 20240403161735 ACCESSION NUMBER: 0001558370-24-004668 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 CORRESP 1 filename1.htm

​

Soligenix, Inc.

29 Emmons Drive, Suite B-10

Princeton, NJ 08540

​

April 3, 2024

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:    

Soligenix, Inc.

Withdrawal of Request for Acceleration of Effectiveness of Registration Statement

Registration Statement on Form S-1, as amended

Commission File No. 333-276511

​

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on April 2, 2024, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for April 3, 2024, at 4:30 p.m. Eastern Daylight Time. We are no longer requesting that such Registration Statement be declared effective at this time, and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,

​

Soligenix, Inc.

​

​

By: /s/ Christopher J. Schaber​ ​​ ​
Christopher J. Schaber, PhD

President and Chief Executive Officer

cc: Driscoll R. Ugarte, Esq.

Duane Morris LLP

​

​